Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer.

Orchekowski R, Hamelinck D, Li L, Gliwa E, vanBrocklin M, Marrero JA, Vande Woude GF, Feng Z, Brand R, Haab BB.

Cancer Res. 2005 Dec 1;65(23):11193-202.

2.

Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.

Gao WM, Kuick R, Orchekowski RP, Misek DE, Qiu J, Greenberg AK, Rom WN, Brenner DE, Omenn GS, Haab BB, Hanash SM.

BMC Cancer. 2005 Aug 23;5:110.

3.

Modulation of cell adhesion molecules in various epithelial cell lines after treatment with PP2.

Calcagno AM, Fostel JM, Orchekowski RP, Alston JT, Mattes WB, Siahaan TJ, Ware JA.

Mol Pharm. 2005 May-Jun;2(3):170-84.

PMID:
15934778
4.
5.

Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit.

Honda S, Tomiyama Y, Pelletier AJ, Annis D, Honda Y, Orchekowski R, Ruggeri Z, Kunicki TJ.

J Biol Chem. 1995 May 19;270(20):11947-54.

6.

Variability of integrin alpha 2 beta 1 activity on human platelets.

Kunicki TJ, Orchekowski R, Annis D, Honda Y.

Blood. 1993 Nov 1;82(9):2693-703.

PMID:
8219222
7.
8.

Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets.

Piotrowicz RS, Orchekowski RP, Nugent DJ, Yamada KY, Kunicki TJ.

J Cell Biol. 1988 Apr;106(4):1359-64.

Supplemental Content

Loading ...
Support Center